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The Role of Patient Activation in Preferences for
Shared Decision Making: Results From a National
Survey of U.S. Adults
SAMUEL G. SMITH1,2, ANJALI PANDIT1, STEVEN R. RUSH3, MICHAEL S. WOLF1, and CAROL J. SIMON4
1Division of General Internal Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
2Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom
3UnitedHealthcare, Minneapolis, Minnesota, USA
4Optum Institute, Minneapolis, Minnesota, USA
Studies investigating preferences for shared decision making (SDM) have focused on associations with sociodemographic variables,
with few investigations exploring patient factors. We aimed to investigate the relationship between patient activation and
preferences for SDM in 6 common medical decisions among a nationally representative cross-sectional survey of American adults.
Adults older than 18 were recruited online (n¼ 2,700) and by telephone (n¼ 700). Respondents completed sociodemographic
assessments and the Patient Activation Measure. They were also asked whether they perceived beneﬁt (yes=no) in SDM in 6
common medical decisions. Nearly half of the sample (45.9%) reached the highest level of activation (Level 4). Activation was
associated with age (p< .001), higher income (p¼ .001), higher education (p¼ .010), better self-rated health (p< .001), and fewer
chronic conditions (p¼ .050). The proportion of people who agreed that SDM was beneﬁcial varied from 53.1% (deciding the
necessity of a diagnostic test) to 71.8% (decisions associated with making lifestyle changes). After we controlled for participant
characteristics, higher activation was associated with greater perceived beneﬁt in SDM across 4 of the 6 decisions. Preferences
for SDM varied among 6 common medical scenarios. Low patient activation is an important barrier to SDM that could be
ameliorated through the development of behavioral interventions.
The health care community is increasingly embracing
shared decision making (SDM; Kon, 2010), with several
large organizations and patient groups recommending
it as the preferred communicative approach in medical
care (Davidson et al., 2007; Institute of Medicine, 2001;
Mercurio, Maxwell, Mears, Ross, & Silber, 2008; Sheridan,
Harris, & Woolf, 2004). These positions are supported by
ethical principles and federal and state laws (Centers for
Medicare and Medicaid Services, 2011; Kuehn, 2009).
Although the deﬁnitions of SDM are contested, clarifying
and including patient preferences within the medical
decision-making process and discussing all available treat-
ment options are generally accepted components (Makoul
& Clayman, 2006). SDM can lead to improved decision
making (Krones et al., 2008; McCaffery, Smith, & Wolf,
2010; Stacey et al., 2014; Zikmund-Fisher, Couper, Singer,
Ubel, et al., 2010) and reduced health care costs (Arterburn
et al., 2012; Veroff, Marr, & Wennberg, 2013; Wennberg,
Marr, Lang, O’Malley, & Bennett, 2010). The relationship
between SDM and health outcomes is mixed (Joosten et al.,
2008; Stacey et al., 2014; Street, Makoul, Arora, & Epstein,
2009; Ward et al., 2003; Wilson et al., 2010).
The nationally representative DECISIONS survey found
that the majority (80%) of Americans had made a medical
decision in the previous 2 years (Zikmund-Fisher, Couper,
Singer, Levin, et al., 2010). However, only 40% to 65% of
the decisions were shared between the patient and the
provider (Zikmund-Fisher, Couper, Singer, Ubel, et al.,
2010). Preferences for involvement in medical decision
making can vary according to the situation (Say, Murtagh,
& Thomson, 2006). For example, members of the public
express more interest in being involved in disease prevention
decisions such as smoking cessation and lifestyle change
(Mansell, Poses, Kazis, & Dueﬁeld, 2000) but prefer to
be more passive in situations with more immediate
consequences (e.g., cancer treatment; Chewning et al.,
2012; Davis, Hoffman, & Hsu, 1999). Yet these generaliza-
tions are not universal, and research investigating variation
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across decision types is needed (Mansell et al., 2000; Waller
et al., 2012).
Early studies showed that patient characteristics such as
male gender, worse self-reported health, and lower socioe-
conomic status predicted less preference for SDM (Arora
& McHorney, 2000; Kiesler & Auerbach, 2006; Say et al.,
2006). However, these studies often used small samples
from speciﬁc clinical populations, which can limit general-
izations. A limited number of nationally representative
studies are available (Levinson, Kao, Kuby, & Thisted,
2005; Zikmund-Fisher, Couper, Singer, Ubel, et al., 2010);
however, additional data are needed that go beyond asso-
ciations with sociodemographic factors, which have
explained comparatively little variance in preferences for
SDM (Say et al., 2006). SDM requires the patient to recog-
nize his or her own values and incorporate them within the
decision-making process. Thus, psychological factors such
as motivation and engagement in a health and medical con-
text may be important concepts to study. To a large extent,
patient activation encapsulates these factors; it refers to the
degree to which an individual possesses knowledge, motiv-
ation, skills, and conﬁdence to make effective health-related
decisions (Hibbard, Mahoney, Stockard, & Tusler, 2005).
Activated patients have better physical and mental health
(Smith, Curtis, Wardle, von Wagner, & Wolf, 2013), more
optimal clinical indicators (Greene & Hibbard, 2012;
Marshall et al., 2013), and lower health care costs (Greene
& Hibbard, 2012). Disparities in activation exist across
economic and ethnic groups (Greene & Hibbard, 2012;
Hibbard & Cunningham, 2008), and simulated models indi-
cate that meaningful reductions in health inequalities could
occur if activation differences were eliminated (Hibbard
et al., 2008).
The relationship between activation and SDM prefer-
ences is underinvestigated, but preliminary evidence sug-
gests that activating patients can increase SDM (Wilkes
et al., 2013). Activated patients seek more health-related
information and are more knowledgeable about health
care (Butler, Farley, Sleath, Murray, & Maciejewski,
2012; Fowles et al., 2009; Harvey, Fowles, Xi, & Terry,
2012). They may therefore be better prepared prior to
consultations and show greater preferences for involve-
ment in medical decision making. To progress the ﬁeld
and inform future intervention strategies, we used nation-
ally representative data to investigate the role of patient
activation and sociodemographic factors within prefer-
ences for SDM across six common medical decisions.
Based on previous evidence, we hypothesized that (a) pre-
ferences for SDM would be higher in situations involving
disease prevention (e.g., screening and lifestyle decisions)
and lower when the consequences are more immediate=
important (e.g., diagnostic testing and treatment); (b)
higher patient activation would be associated with
greater perceived beneﬁt in SDM; (c) members of lower
socioeconomic groups (as measured by income, education,
and race), men, younger respondents, and those with
worse health would have lower levels of activation; and
(d) members of lower socioeconomic groups, younger
respondents, and those with better health would perceive
less beneﬁt in SDM.
Methods
Design
Data were from a nationally representative survey of
English-speaking U.S. adults age 18 years and older. The
survey was conducted by Harris Interactive between August
14 and September 17, 2013. To ensure full representation of
U.S. adults, a mixed-mode methodology was used that com-
bined an online panel (n¼ 2,700) and random-digit dialing
(RDD; n¼ 700) sampling and data collection. The telephone
sample included landline and cell phone connections and
was randomized prior to dialing. For the online sample, a
consumer research panel associated with Harris Interactive
was stratiﬁed by U.S. Census parameters (education, age
by gender, race, region, and household income) and then
invited by e-mail to take part in a self-administered survey
(U.S. Census Bureau, 2012). The e-mail invitation included
a secure and unique URL and password to ensure that the
respondent could only complete one survey. Excluding dis-
connected lines, a total of 15,050 working phone numbers
yielded 838 participating respondents, for an overall
response rate of 5.6% in the RDD sample. Of the 838
respondents who were screened, 700 met the age qualiﬁ-
cation (U.S. resident, age 18 or older) speciﬁed in the study
design. A response rate for the online sample is not reported
as probability sampling was not used.
In accordance with polling industry standards, respon-
dents’ conﬁdentiality was ensured such that they were not
identiﬁed by name or any other personal identiﬁers. As
a member of the Council of American Survey Research
Organizations (CASRO), the research company conducted
this survey in accordance with the CASRO Code of
Standards and Ethics for Survey Research.
Measures
SDM
To assess preferences for patient involvement in SDM,
a series of common medical decisions were presented to
respondents with the following introductory statement:
There has been much discussion lately about patients
participating with their healthcare providers in making
decisions about their health. For which of these topic
areas do you think it is beneﬁcial for patients to share
in decisions with their healthcare provider?
The following medical decisions were provided: lifestyle
changes, such as diet and exercise; preventive screening tests;
choosing between completely different approaches to treat-
ing a diagnosed condition (e.g., medication vs. surgery);
choosing a specialist for referral; choosing between different
medications that might be prescribed for a diagnosed
condition; and deciding whether it is necessary to have a
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diagnostic test. The response items were yes and no. To
prevent ordering effects, the decisions were presented in
a random order for each participant.
Patient Activation Measure
Patient activation was assessed using the Patient Activation
Measure Short Form (Hibbard et al., 2005). This is a 13-item
measure designed to assess self-reported knowledge, skill,
and conﬁdence for self-management of one’s health and
chronic conditions. The measure has been shown to be
reliable and valid across a range of clinical conditions and
contexts (Hibbard, Stockard, Mahoney, & Tusler, 2004;
Hung et al., 2013; Skolasky et al., 2011). Participants were
asked to respond to statements that people sometimes make
when they talk about their health. Example statements
included ‘‘When all is said and done, I am the person who
is responsible for managing my health condition(s)’’ and ‘‘I
am conﬁdent that I can take actions that will help prevent
or minimize some symptoms or problems associated with
my health condition(s).’’ Response items included strongly
disagree, slightly disagree, slightly agree, strongly agree, not
applicable, don’t know, and refused. A score of 0 (low
activation) to 100 (high activation) was computed, and
respondents were classiﬁed into four levels of activation
using predeﬁned cutoffs: Level 1—may not yet believe that
the patient role is important (0–45.2), Level 2—lacks conﬁ-
dence and knowledge to take action (47.4–52.9), Level 3—
beginning to take action (56.4–66.0), Level 4—has difﬁculty
maintaining behaviors over time (68.5–100). The measure
had good internal reliability in this sample (a¼ .90).
Participant Characteristics
Data on gender, age, race (White, Black, Asian or Paciﬁc
Islander, other), income (<$15,000, $15,000–$34,999,
$35,000–$49,999, $50,000þ), education (high school or less,
some college, college graduate, graduate school), region
(East, Midwest, South, West), self-rated health (poor, fair,
good, very good, excellent), and self-reported chronic
conditions (0, 1, or 2þ) were collected.
Statistical Analysis
RDD data were weighted to U.S. Census targets for edu-
cation, age by gender, race, region, and household income
to bring them into line with the population of U.S. residents
age 18 and older (U.S. Census Bureau, 2012). The weighting
algorithm also took into account landline versus cell phone
usage using information from the 2012 National Health
Interview Survey (Blumberg & Luke, 2012) and probability
of selection using number of telephone lines, number of
adults in the household, and recent absence of a phone
connection. The online data were also weighted to the same
applicable parameters as the telephone RDD sample.
However, the algorithm included a propensity score that
allowed for adjustment for attitudinal and behavioral
differences between online and ofﬂine populations, those
who join online panels, and likelihood of response.
The RDD and online sample data were combined into
a proportioned total using Internet usage information
(Pew Research Center, 2013).
Complex samples analyses using the weighting variable
were performed using the following statistical tests. Chi-
square analyses explored which participant characteristics
were associated with patient activation. Odds ratios (ORs)
and 95% conﬁdence intervals (CIs) for the associations
between patient activation, participant characteristics, and
perceived beneﬁt in SDM in each decision were computed
using multivariate logistic regression. Signiﬁcance was set at
p< .05, and all analyses were performed in SPSS Version 22.
Results
Sample Characteristics
As shown in Table 1, the weighted analyses showed that
respondents were more likely to be female (52.8%), younger
(18–30¼ 21.9%, 31–40¼ 16.6%), White (77.5%), and from
the southern United States (33.4%). Half (50.0%) of the
respondents had an income >$50,000, and more than
a quarter (28.0%) had at least a university-level education.
Self-reported health was high (good¼ 35.9%, very good¼
33.4%, excellent¼ 14.1%), and the majority reported no
chronic conditions (66.5%). In line with the recruitment
strategy, most people completed the survey online (77.0%).
Patient Activation
The mean level of patient activation was 66.6 (SD¼ 16.8).
There were fewer people in the lower levels of patient acti-
vation (Level 1¼ 11.3%, Level 2¼ 13.0%, Level 3¼ 29.8%),
with nearly half (45.9%) of the sample reaching the highest
level of activation (Level 4). There was a relationship
between patient activation and age (p< .001). Respondents
age 61–70 were most likely to be in the highest level of
activation (53.7%), and the youngest and oldest age groups
were less likely (see Table 1). Income (p¼ .001) and
education (p¼ .010) were signiﬁcantly associated with patient
activation. The highest levels of activation were observed
in those with the highest income ($50,000þ¼ 52.1%) and
highest education (graduate school¼ 54.8%). Asians or
Paciﬁc Islanders (31.7%) or the ‘‘other’’ race category
(39.0%) had notably lower levels of activation, but there
was no overall effect of race (p¼ .149). Respondents with
better self-rated health (p< .001) and fewer chronic con-
ditions (p¼ .050) were more likely to have higher activation.
Activation levels were similar between genders (p¼ .400),
regions (p¼ .804), and survey modes (p¼ .317).
SDM
Respondents generally indicated that they saw beneﬁt in SDM
across all medical decisions (see Table 2). The proportion of
endorsement ranged from 53.1% (deciding the necessity of
a diagnostic test) to 71.8% (decisions regarding lifestyle
changes). Table 2 describes the relationship between SDM
and patient activation in univariate analyses for each of
the six decisions. Differences were observed for lifestyle
(p< .001), preventive screening (p< .001), choosing treat-
ments (p¼ .012), choosing between medications (p¼ .018),
and deciding the necessity of a diagnostic test (p¼ .021). There
Patient Activation and Shared Decision Making 69
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Table 2. Likelihood of perceived beneﬁt in shared decision making by decision type and activation level
Decision type Overall (%) Level 1 (%) Level 2 (%) Level 3 (%) Level 4 (%) v2
Lifestyle change 71.8 62.6 70.5 71.5 77.8 .000
Preventive screening tests 59.2 47.6 59.7 59.1 64.6 .000
Choosing between different treatment approaches 60.1 56.1 58.7 57.7 65.7 .012
Choosing a specialist for referral 54.7 52.7 56.0 56.9 55.6 .804
Choosing between different medications 58.0 49.7 58.6 58.1 62.3 .018
Deciding the necessity of a diagnostic test 53.1 50.2 50.1 51.3 58.5 .021
Table 1. Participant characteristics and percentage at highest level of activation
Characteristic n % Level 1 Level 2 Level 3 Level 4 v2 signiﬁcance
Gender
Male 1,382 47.2 12.4 12.1 30.3 45.2 .400
Female 2,018 52.8 10.2 13.8 29.4 46.6
Age
18–30 585 21.9 16.4 12.3 26.2 45.0 .000
31–40 537 16.6 7.6 11.3 34.2 47.0
41–50 608 18.5 14.4 11.5 29.3 44.9
51–60 649 17.3 8.9 12.2 33.5 45.4
61–70 656 16.1 7.4 12.7 26.2 53.7
71–80 281 7.3 12.1 19.6 30.9 37.4
80þ 84 2.4 7.1 28.9 32.1 32.0
Ethnicity
White 2,717 77.5 10.0 12.8 30.5 46.7 .149
Black 346 11.4 12.9 10.5 27.2 49.5
Asian or Paciﬁc Islander 101 2.2 18.1 18.4 31.7 31.7
Other 199 8.9 16.4 16.4 28.2 39.0
Income
<$15,000 396 9.7 15.1 16.5 30.0 38.4 .001
$15,000–$34,999 773 18.3 13.1 15.5 30.2 41.2
$35,000–$49,999 449 12.9 14.0 14.7 31.7 39.6
>$50,000 1,500 50.0 8.4 10.6 28.8 52.1
Missing 282 9.2 15.1 14.7 31.8 38.4
Education
High school or less 884 43.2 13.9 13.9 29.8 42.3 .010
Some college 1,202 28.9 9.8 12.6 32.7 45.0
College graduate 886 20.4 8.4 12.3 27.4 51.9
Graduate school 411 7.6 10.2 11.1 23.9 54.8
Region
East 764 21.5 10.3 12.5 31.6 45.5 .804
Midwest 833 22.4 11.3 12.4 31.8 44.5
South 1,041 33.4 10.6 12.5 29.0 47.9
West 762 22.7 13.0 14.8 27.3 44.8
Survey mode
Online 2,700 77.0 10.8 12.5 29.7 47.1 .317
Phone 700 23.0 12.9 14.7 30.3 42.1
Self-rated health
Poor 132 3.6 27.6 17.5 20.3 34.6 .000
Fair 514 13.0 22.8 18.0 29.2 29.9
Good 1,324 35.9 13.0 16.5 34.7 35.8
Very good 1,042 33.4 5.4 9.4 30.4 54.7
Excellent 388 14.1 6.2 6.9 19.3 67.5
Chronic conditions
0 983 33.5 7.9 11.9 32.1 48.1 .050
1 816 24.3 11.2 13.4 30.1 45.2
2þ 1,601 42.2 13.8 13.5 28.0 44.7
Note. n may not round to 3,400 because of missing data; percentages are weighted.
70 S. G. Smith et al.
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were no differences across activation groups for the decision
related to choosing a specialist for referral (p¼ .804).
In multivariate analyses, patient activation was associated
with perceived beneﬁt in SDM in four of the six decisions
(see Table 3). Compared with the reference category (low acti-
vation, Level 1), respondents with the highest level of
activation (Level 4) were more likely to see beneﬁt in SDM
for decisions related to lifestyle (OR¼ 2.13, 95% CI [1.43,
3.18]), preventive screening (OR¼ 2.02, 95% CI [1.41, 2.91]),
choosing treatments (OR¼ 1.50, 95% CI [1.00, 2.13]), and
choosing medications (OR¼ 1.82, 95% CI [1.25, 2.66]).
Respondents in Level 3 activation were more likely to see
beneﬁt in SDM for decisions related to preventive screening
(OR¼ 1.65, 95% CI [1.14, 2.38]) and choosing medications
(OR¼ 1.53, 95% CI [1.04, 2.24]). Respondents in Level 2 acti-
vation were only more likely to see beneﬁt for the preventive
screening decision (OR¼ 1.62, 95% CI [1.08, 2.44]).
To various extents, participant characteristics were asso-
ciated with SDM preferences. Women were more likely to
see beneﬁt in the decisions related to choosing treatment
(OR¼ 1.44, 95% CI [1.17, 1.78]) and choosing a specialist
(OR¼ 1.46, 95% CI [1.19, 1.79]). Older respondents
were generally more likely to see beneﬁt in SDM than the
youngest participants. Black respondents were less likely to
see beneﬁt in decisions related to medication choice
(OR¼ 0.81, 95% CI [0.58, 1.13]), whereas Asian or Paciﬁc
Islanders were less likely to see beneﬁt in choosing treat-
ments (OR¼ 0.45, 95% CI [0.26, 0.81]) and choosing
Table 3.Weighted multivariate logistic regression predicting a ‘‘yes’’ response to seeing perceived beneﬁt in shared decision making
Characteristic
Lifestyle
Preventive
screening
Choosing
treatments Choosing specialists
Choosing
medications
Diagnostic
testing
OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI]
Gender
Male Ref Ref Ref Ref Ref Ref
Female 1.21 [0.97, 1.53] 1.10 [0.90, 1.36] 1.44 [1.17, 1.78] 1.46 [1.19, 1.79] 1.18 [0.96, 1.44] 1.14 [0.93, 1.39]
Age
18–30 Ref Ref Ref Ref Ref Ref
31–40 1.08 [0.75, 1.55] 1.30 [0.92, 1.83] 0.95 [0.67, 1.35] 0.97 [0.68, 1.36] 1.02 [0.72, 1.44] 1.12 [0.79, 1.59]
41–50 1.10 [0.77, 1.58] 1.25 [0.89, 1.75] 0.99 [0.71, 1.39] 0.92 [0.66, 1.28] 1.06 [0.76, 1.48] 1.21 [0.87, 1.70]
51–60 2.03 [1.37, 3.00] 2.05 [1.45, 2.89] 1.63 [1.15, 2.30] 1.69 [1.21, 2.36] 1.38 [0.98, 1.93] 1.80 [1.29, 2.52]
61–70 1.65 [1.13, 2.41] 2.06 [1.44, 2.94] 1.49 [1.04, 2.14] 1.81 [1.29, 2.55] 1.35 [0.95, 1.92] 2.09 [1.47, 3.00]
71–80 1.86 [1.07, 3.22] 2.57 [1.57, 4.20] 1.46 [0.93, 2.31] 1.84 [1.16, 2.95] 1.12 [0.71, 1.77] 2.33 [1.49, 3.64]
80þ 1.49 [0.70, 3.17] 1.29 [0.69, 2.45] 1.18 [0.61, 2.28] 2.05 [1.02, 4.11] 1.30 [0.67, 2.53] 2.83 [1.44, 5.58]
Ethnicity
White Ref Ref Ref Ref Ref Ref
Black 0.87 [0.60, 1.26] 0.77 [0.55, 1.07] 0.81 [0.58, 1.13] 1.03 [0.74, 1.43] 0.67 [0.48, 0.93] 0.86 [0.61, 1.21]
Asian or Paciﬁc
Islander
0.92 [0.42, 2.00] 0.53 [0.27, 1.05] 0.45 [0.26, 0.81] 0.59 [0.28, 1.23] 0.47 [0.25, 0.89] 0.83 [0.42, 1.63]
Other 1.22 [0.79, 1.88] 1.07 [0.71, 1.62] 1.61 [1.04, 2.50] 1.49 [0.99, 2.23] 1.42 [0.94, 2.13] 1.80 [1.19, 2.72]
Income
<$15,000 Ref Ref Ref Ref Ref Ref
$15,000–$34,999 0.87 [0.58, 1.30] 1.21 [0.83, 1.77] 1.22 [0.84, 1.76] 1.41 [0.98, 2.03] 0.91 [0.63, 1.33] 0.97 [0.67, 1.41]
$35,000–$49,999 1.09 [0.69, 1.73] 1.09 [0.72, 1.66] 1.05 [0.69, 1.59] 1.17 [0.77, 1.78] 0.96 [0.63, 1.45] 0.77 [0.51, 1.18]
$50,000þ 0.98 [0.67, 1.45] 1.12 [0.78, 1.61] 0.97 [0.68, 1.39] 1.42 [0.99, 2.04] 0.93 [0.65, 1.34] 0.95 [0.66, 1.37]
Missing 1.43 [0.82, 2.49] 2.16 [1.29, 3.60] 1.14 [0.71, 1.85] 2.59 [1.58, 4.24] 1.36 [0.81, 2.26] 1.43 [0.87, 2.35]
Education
High school or less Ref Ref Ref Ref Ref Ref
Some college 1.47 [1.12, 1.95] 1.24 [0.96, 1.59] 1.12 [0.87, 1.44] 1.15 [0.89, 1.47] 0.92 [0.71, 1.18] 1.00 [0.78, 1.28]
College graduate 1.70 [1.23, 2.40] 1.60 [1.18, 2.15] 1.63 [1.21, 2.19] 1.24 [0.92, 1.65] 1.03 [0.78, 1.37] 1.02 [0.76, 1.37]
Graduate school 1.99 [1.28, 3.11] 1.57 [1.06, 2.31] 2.54 [1.71, 3.79] 1.57 [1.08, 2.28] 1.17 [0.81, 1.68] 0.92 [0.63, 1.32]
Patient activation
Level 1 Ref Ref Ref Ref Ref Ref
Level 2 1.33 [0.86, 2.08] 1.62 [1.08, 2.44] 1.06 [0.70, 1.60] 1.13 [0.74, 1.70] 1.47 [0.97, 2.22] 0.92 [0.61, 1.38]
Level 3 1.42 [0.95, 2.12] 1.65 [1.14, 2.38] 1.05 [0.71, 1.54] 1.25 [0.86, 1.83] 1.53 [1.04, 2.24] 1.04 [0.71, 1.51]
Level 4 2.13 [1.43, 3.18] 2.02 [1.41, 2.91] 1.50 [1.00, 2.13] 1.17 [0.81, 1.71] 1.82 [1.25, 2.66] 1.31 [0.97, 2.05]
Self-rated health
Poor 1.35 [0.62, 2.93] 1.80 [0.88, 3.66] 1.39 [0.68, 2.82] 2.93 [1.51, 5.69] 1.51 [0.73, 3.13] 1.95 [0.95, 4.00]
Fair 1.41 [0.88, 2.28] 1.13 [0.73, 1.74] 0.99 [0.64, 1.52] 1.22 [0.81, 1.85] 0.91 [0.59, 1.41] 0.82 [0.53, 1.25]
Good 1.37 [0.93, 2.03] 0.80 [0.56, 1.12] 0.89 [0.62, 1.26] 0.87 [0.62, 1.23] 0.81 [0.57, 1.15] 0.67 [0.48, 0.95]
Very good 1.40 [0.95, 2.05] 0.87 [0.61, 1.23] 1.03 [0.73, 1.45] 1.09 [0.78, 1.52] 0.85 [0.60, 1.19] 0.79 [0.56, 1.11]
Excellent Ref Ref Ref Ref Ref Ref
Chronic conditions
0 Ref Ref Ref Ref Ref Ref
1 0.99 [0.74, 1.34] 1.17 [0.90, 1.55] 1.17 [0.88, 1.54] 0.95 [0.72, 1.25] 1.19 [0.98, 1.69] 0.98 [0.74, 1.29]
2þ 1.34 [0.99, 1.82] 1.32 [1.00, 1.72] 1.36 [1.04, 1.79] 1.16 [0.90, 1.51] 1.62 [1.25, 2.11] 1.14 [0.88, 1.49]
Note. OR¼odds ratio; CI¼ conﬁdence interval.
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medications (OR¼ 0.47, 95% CI [0.25, 0.89]). Members of
the ‘‘other’’ race category were more likely to see beneﬁt in
choosing treatments (OR¼ 1.61, 95% CI [1.04, 2.50]) and
diagnostic testing (OR¼ 1.80, 95% CI [1.19, 2.72]). Income
was rarely a predictor of SDM preferences, with the
exception of the ‘‘missing’’ category and decisions related
to preventive screening (OR¼ 2.16, 95% CI [1.29, 3.60])
and choosing a specialist (OR¼ 2.59, 95% CI [1.58, 4.24]).
Higher education was associated with preferences for
SDM. For example, compared with the least educated (high
school or less), those who attended graduate school weremore
likely to perceive beneﬁt in SDM for decisions related to
lifestyle (OR¼ 1.99, 95% CI [1.28, 3.11]), preventive screening
(OR¼ 1.57, 95% CI [1.06, 2.31]), choosing treatments
(OR¼ 2.54, 95% CI [1.71, 3.79]), and choosing specialists
(OR¼ 1.57, 95% CI [1.08, 2.28]). Respondents with college
education were more likely to perceive beneﬁt in the decisions
related to lifestyle (OR¼ 1.70, 95%CI [1.23, 2.40]), preventive
screening (OR¼ 1.60, 95% CI [1.18, 2.15]), and choosing
treatment (OR¼ 1.63, 95% CI [1.21, 2.19]).
The impact of health status varied across decisions.
Compared with those with excellent self-reported health,
respondents with poor self-rated health were more likely to
see beneﬁt in SDM when choosing a specialist (OR¼ 2.93,
95% CI [1.51, 5.69]). Respondents with good health were less
likely to see beneﬁt in SDM in diagnostic testing (OR¼ 0.67,
95% CI [0.56, 1.11]), but there was no discernable effect for
fair or very good health. Those with two or more chronic
conditions were more likely to see beneﬁt in SDM for
decisions related to preventive screening (OR¼ 1.32, 95%
CI [1.00, 1.72]), choosing treatment (OR¼ 1.36, 95% CI
[1.04, 1.79]), and choosing medications (OR¼ 1.62, 95% CI
[1.25, 2.11]).
Discussion
In this nationally representative survey the majority of U.S.
adults perceived at least some beneﬁt in SDM, but there was
a sizeable minority who did not. The attitudes of the
population should be considered by large organizations
and policymakers who are increasingly advocating a pos-
ition of SDM (Davidson et al., 2007; Institute of Medicine,
2001; Mercurio et al., 2008; Sheridan et al., 2004). Perceived
beneﬁt in SDM varied according to the decision. Patients
preferred greater involvement in decisions involving disease
prevention (e.g., screening) and lifestyle change. Less
perceived beneﬁt was reported for decisions involving
immediate consequences, such as deciding the necessity of
a diagnostic test. However, this assertion did not generalize
to decisions involving treatment and medication, for which
the consequences may also be expected to be important
and immediate. Overall, estimates of interest in SDM
broadly reﬂected actual occurrences of SDM reported
in a nationally representative sample (Zikmund-Fisher,
Couper, Singer, Ubel, et al., 2010).
Although our study design prohibits inferences of
causality, our ﬁndings suggest that low levels of patient
activation may be a barrier to SDM. Respondents reaching
the highest activation level were consistently more likely to
perceive beneﬁt in SDM across all medical decisions, with
the exception of choosing a specialist. The relationship
between activation and perceived beneﬁt in SDM among
the lower levels of activation (Levels 2 and 3) was less
consistent. For example, compared with the least activated
respondents, those classiﬁed at Levels 2, 3, or 4 of activation
were more likely to see beneﬁt in SDM in the preventive
screening decision and in choosing medications. However,
for other decisions (e.g., lifestyle changes and choosing
medical treatments), it was not until the highest levels of
activation were reached that respondents perceived beneﬁt.
Patient activation appeared to affect preferences most
in decisions regarding preventive screening and choosing
medications, in which even moderately activated respondents
preferred greater involvement than those who were least
activated. In contrast, decisions involving lifestyle changes
and choosing treatments may need patients to increase to
the highest activation level before beneﬁts will be seen in
terms of SDM preferences. Interventions such as preparing
patients prior to consultations through preference elicitation
and clariﬁcation have been somewhat effective at increasing
activation (Deen, Lu, Rothstein, Santana, & Gold, 2011).
However, they may not be sufﬁciently effective among the
least activated for improvements to be seen in SDM prefer-
ences in some decisions. Decisions involving treatment
choices may require alternative multifaceted approaches,
such as decision aids plus patient preparation, to promote
the necessary amount of activation (Deen et al., 2012;
Hibbard, Greene, & Tusler, 2009).
Our data indicated that a little less than half (45.9%) of
the population were classiﬁed as having Level 4 activation,
which is reﬂective of previous national estimates (Hibbard
& Cunningham, 2008). Our data also support evidence
showing that patient activation is associated with markers
of socioeconomic status, including income and education,
and other demographic factors, such as age (Greene &
Hibbard, 2012; Hibbard & Cunningham, 2008). Patient
activation was higher among healthier individuals, as
measured by self-reported health and the number of chronic
conditions. To our knowledge, this has not been reported
in nationally representative samples, although it has been
suggested by research in speciﬁc clinical populations
(Chubak et al., 2012). In contrast to previous national
estimates, there was no overall effect of race on patient
activation levels (Hibbard & Cunningham, 2008). However,
the prevalence of high activation among Asian and Paciﬁc
Islander respondents was noticeably lower than among the
other ethnicities. We found no evidence of gender differ-
ences, but only small effects were noted in the large sample
reported by Hibbard and Cunningham (2008).
In line with previous research, low education was consist-
ently associated with perceiving less beneﬁt in SDM (Arora
& McHorney, 2000). One possibility is that people with low
levels of education lack the skills to adequately process
health information and therefore prefer to rely on expert
opinion to make medical decisions. The term health literacy
generally describes these skills and has been deﬁned by the
Institute of Medicine as ‘‘the degree to which individuals
72 S. G. Smith et al.
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have the capacity to obtain, process and understand basic
health information and services needed to make appropriate
health decisions’’ (Ratzan & Parker, 2000, p. 19). In previous
analyses we showed that health literacy and patient
activation inﬂuenced health outcomes through different
pathways, and this may also be the case with SDM (Smith
et al., 2013). Future research should consider investigating
the importance of these two variables in the formation of
SDM preferences.
No effects were consistently observed for income on SDM
preferences, perhaps because of confounding with education.
Effects by race were observed, with respondents classiﬁed as
‘‘other’’ more likely to see beneﬁt in choosing treatments,
specialists, and diagnostic testing. Differences across race=
ethnicity were also observed for the treatment and medica-
tions decisions. In support of previous ﬁndings we observed
higher preferences for SDM among those who were older
(Levinson et al., 2005), but gender effects did not often
reach statistical signiﬁcance. These inconsistencies across
conditions further emphasize the importance of specifying
the type of decision when asking about SDM preferences.
They also highlight areas in which disparities are most likely
to occur, providing guidance for prospective interventions.
This study has limitations. Items were phrased to ask
whether respondents could ‘‘see beneﬁt’’ in SDM rather than
speciﬁcally using the word preference. The introductory
statement to the SDM item had a readability score of 46
out of 100, which is equivalent to a reading age of 16 years.
The text may therefore have been difﬁcult for people with
lower levels of literacy to comprehend. The study is further
limited by the simplicity of the items used. Alternative
approaches (e.g., qualitative approaches) may yield a richer
data set but would be limited by their low external validity
(Edwards & Elwyn, 2006; Elwyn, Edwards, Kinnersley, &
Grol, 2000). The decisions presented were hypothetical,
and therefore reported preferences may not reﬂect attitudes
held by patients actually making those judgments. Similarly,
we were unable to collect data on previous experience with
decision making, and it is unclear whether respondents had
experience in each scenario. Response and selection biases
were limited through weighting procedures, but it is possible
that the online panel sample may have been more activated
than an ofﬂine population. We may therefore have overesti-
mated the level of patient activation in the general U.S.
sample, and associations with demographic variables may
be conservative estimates. The response rates in our RDD
survey were also low in comparison with similar studies
(Cantor et al., 2009; Cantor, Covell, Davis, Park, & Rizzo,
2007). Finally, it should be acknowledged that our data were
cross-sectional, which limits our ability to assert causality.
Conclusions
In conclusion, this nationally representative study indicates
that there is a discord between policy and public attitudes
toward SDM. Although clinicians are encouraged to pro-
mote SDM, a large proportion of the public in this study
reported not perceiving any beneﬁt in the practice. Patient
activation was a consistent predictor of SDM preferences,
indicating that intervention strategies targeting the construct
may have beneﬁcial effects on public attitudes toward com-
munication and decision making in clinical encounters.
Further prospective and experimental research is warranted
on the basis of these ﬁndings.
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